FINWIRES · TerminalLIVE
FINWIRES

Cadence Design Systems 扩大与英伟达的合作关系,并与谷歌在人工智能芯片设计和加速计算领域展开合作。

-- Cadence Design Systems (CDNS) 周三分别发布新闻稿宣布,公司扩大了与英伟达 (Nvidia, NVDA) 的合作关系,并与 Alphabet (GOOG/GOOGL) 旗下的谷歌达成合作。 Cadence 在一份声明中表示,公司将与英伟达合作,通过结合其电子设计自动化 (EDA) 系统与英伟达 CUDA-X 和 Omniverse 库,提供涵盖智能体人工智能 (Agent-AI) 和基于物理的仿真服务,以提高半导体设计中的生产效率并加快工程流程。 Cadence 还表示,英伟达将在其芯片设计流程中采用 Cadence 的 AgentStack,两家公司还将专注于嵌入式智能体人工智能,以开发自主机器。 Cadence 将与谷歌合作,利用谷歌云上的 Gemini 平台优化 Cadence ChipStack AI 超级智能体,以推进向智能体设计自动化的转型。 Cadence 还表示,该公司正在加强 Gemini 超级代理与 Cadence EDA 引擎之间的集成,同时利用 Google 的基础设施为 Gemini 的大型语言模型推理提供计算能力。

Price: $302.86, Change: $+10.49, Percent Change: +3.59%

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL